Predictors of chronic valvular disease in patients with rheumatic carditis

Murat Muhtar Yilmazer1, Taliha Oner, Vedide Tavlı

  • 1Department of Pediatric Cardiology, Izmir Dr. Behçet Uz Children's Hospital, Izmir, Turkey. drmuratmuhtar@hotmail.com

Pediatric Cardiology
|September 28, 2011
PubMed

Insights

Left ventricular dilation predicts persistent valvular disease in children with rheumatic carditis. Early signs like cardiac murmur indicate ongoing mitral regurgitation, impacting long-term outcomes.

Area of Science:

  • Pediatric Cardiology
  • Rheumatic Heart Disease
  • Cardiovascular Research

Background:

  • Rheumatic carditis can lead to chronic valvular disease in children.
  • Predictors of disease persistence require further investigation for improved management.
  • Understanding long-term outcomes is crucial for pediatric cardiac care.

Purpose of the Study:

  • To identify predictors of chronic valvular disease in pediatric rheumatic carditis patients.
  • To evaluate the association between initial clinical findings and disease progression.
  • To determine factors influencing the persistence of valvular involvement and mitral regurgitation.

Main Methods:

  • Retrospective review of 88 pediatric patients with chronic rheumatic heart disease.
  • Short- to mid-term follow-up data analysis (mean 2.95 years).
  • Multivariate logistic regression to identify significant risk factors.

Main Results:

  • Initial left ventricular dilation was a significant independent risk factor for persistent valvular involvement or mitral regurgitation.
  • Persistence of mitral regurgitation strongly correlated with cardiac murmur at admission.
  • No significant correlation found between age, gender, or initial valvular severity and chronic valvular disease.
  • Subclinical carditis showed a better outcome than clinically evident carditis.

Conclusions:

  • Left ventricular dilation is a key predictor of persistent valvular disease in pediatric rheumatic carditis.
  • Cardiac murmur at admission is a marker for ongoing mitral regurgitation.
  • Myocardial involvement, independent of valvular regurgitation, may contribute to left ventricular dilation.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...